DORAL, Florida, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces its partnerships with communication agencies Les Fous de la Com and Priori System to promote the Hygee™ medical device for the self-screening of Chlamydia.
Per the agreement, Les Fous de La Com will focus on building a strong online presence for the Hygee™ product via a dedicated website, currently under construction, and an open communication channel with journalisms. The website will be written in common language to ensure that all of the members of the target audience – women at risk for contracting Chlamydia – can understand the message.
“It is a privilege to leverage our words and online marketing strategies to contribute to the success of an international health company like Earth Science. More so, we look forward to applying our expertise to the advancement of Hygee™ in the marketplace. The goal of our efforts is to create brand recognition and awareness of the different facets of the product, including its importance, distribution and availability, as well as the associated laboratory testing service, and the importance of testing,” states Denis Foucault, president of Les Fous de La Com.
As previously announced, Hygee™ is a new trademark owned by ETST that will be officially launched at the end of January, barring opposition. Since Hygee™ and the description of its logo are published on the U.S. Patent and Trademark website, interested parties can do a Trademark search on the website using the TESS data base by clicking the button “Find It Fast.”
Priori System will work to endow the Hygee™ trademark with the visibility that will be required to develop partnerships and associations at local, national and international levels.
“We are delighted to work with Earth Science in the promotion of Hygee™, as it stands to improve the quality of life of women everywhere on the planet,” states Priori System President Christian Dumont. “The goal is to bring Hygee™ to women everywhere, making the product and the service so well known that we can finally begin to ease the catastrophe of Chlamydia and other sexually transmitted infections.”
According to the Centers for Disease Control, more than 2 million cases of chlamydia, gonorrhea and syphilis were reported in the United States alone in 2016, the highest number on record. Chlamydia accounted for the majority of these new diagnoses (1.6 million).
In light of these record numbers, medical literature consistently publishes new papers that recommend more Chlamydia screening in pregnant and young women around the world. ETST believes that Hygee™ is the answer to this global epidemic.
“Hygee™ is a concept that has the potential to revolutionize the way we screen for major sexually transmitted infections. I urge anyone truly interested in this subject to read Chapter 10 of the book Major Infectious Diseases. 3rd edition by Chesson, Mayaud, and Aral. It is available on the web,” states Dr. Michel Aubé, ETST CEO and Chief Science Officer.
Nickolas S. Tabraue, chairman of ETST, adds, “We know that we now have the means to stem the tide of this epidemic. To do that, we need the legislative support of governments and the medical community. But let me be very clear. This will work because we will put Hygee™ in the hands of the women who need it. We are going to give women control over their own testing, and their own bodies. As confident as we are in our product, that is going to take a community, not a company.”
In addition to their focus on Hygee™, Les Fous de la Com and Priori System Marketing will work concurrently to improve the e-marketing of ETST’s High Grade Full Spectrum Hemp Oil Cannabinoids™ and its derivative products. This is expected to increase the Company’s online sales and help to recruit more partner stores.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors:
Earth Science Pharmaceutical, Inc.
Earth Science Pharmaceutical ("ESP") is a wholly-owned subsidiary of Earth Science Tech, committed to the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the Company’s research and development efforts. The Company’s first medical device, Hygee™, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly-owned subsidiary of Earth Science Tech, Inc. poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
KannaBidioiD (“KBD”) is a wholly-owned subsidiary of Earth Science Tech, Inc. that provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy. To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation, Inc.
Earth Science Foundation (“ESF”) is a wholly-owned subsidiary of Earth Science Tech, Inc. ESF is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech's effective CBD products to those in need. To learn more please visit: www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Nickolas S. Tabraue
President, Director & Chairman